RFID still garners big forecast

Vendors are offering pilot kits to help drugmakers get a handle on the little understood business case for RFID technology. Delays in retailer and regulatory supply chain mandates have hampered adoption, says GBI Research, which forecasts annual industry growth of 34 percent through 2015, in a $3,500 report. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.